Insulin glargine and lixisenatide and Sodium Lactate
Determining the interaction of Insulin glargine and lixisenatide and Sodium Lactate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: sodium lactate
Brand name: Iodopen
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Sodium Nitrite
- Insulin glargine and lixisenatide-Sodium nitrite and sodium thiosulfate
- Insulin glargine and lixisenatide-Sodium nitrite and sodium thiosulfate Intravenous
- Insulin glargine and lixisenatide-Sodium Nitrite Injection
- Insulin glargine and lixisenatide-Sodium Nitroprusside
- Insulin glargine and lixisenatide-Sodium Nitroprusside Injection
- Sodium Lactate-Insulin glargine and lixisenatide Subcutaneous
- Sodium Lactate-Insulin glargine, recombinant Subcutaneous
- Sodium Lactate-Insulin glulisine
- Sodium Lactate-Insulin Glulisine (Cartridges and Pens)
- Sodium Lactate-Insulin Glulisine (Vials)
- Sodium Lactate-Insulin glulisine Subcutaneous